[go: up one dir, main page]

EE200200323A - RG1 polüpeptiidi kodeeriv DNA - Google Patents

RG1 polüpeptiidi kodeeriv DNA

Info

Publication number
EE200200323A
EE200200323A EEP200200323A EEP200200323A EE200200323A EE 200200323 A EE200200323 A EE 200200323A EE P200200323 A EEP200200323 A EE P200200323A EE P200200323 A EEP200200323 A EE P200200323A EE 200200323 A EE200200323 A EE 200200323A
Authority
EE
Estonia
Prior art keywords
polypeptides
polypeptide
dna encoding
methods
polynucleotides
Prior art date
Application number
EEP200200323A
Other languages
English (en)
Inventor
Harkins Richard
Parkes Deborah
Parry Gordon
W. Schneider Douglas
Steinbrecher Renate
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200323A publication Critical patent/EE200200323A/et
Publication of EE05293B1 publication Critical patent/EE05293B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
EEP200200323A 1999-12-16 2000-12-15 RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine EE05293B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (en) 1999-12-16 2000-12-15 Polynucleotid encoding the rg1 polypeptide

Publications (2)

Publication Number Publication Date
EE200200323A true EE200200323A (et) 2003-10-15
EE05293B1 EE05293B1 (et) 2010-04-15

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200323A EE05293B1 (et) 1999-12-16 2000-12-15 RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine

Country Status (32)

Country Link
US (5) US6682902B2 (et)
EP (2) EP2048157B1 (et)
JP (1) JP4979867B2 (et)
KR (1) KR100752434B1 (et)
CN (1) CN1297566C (et)
AT (1) ATE440862T1 (et)
AU (1) AU784674B2 (et)
BG (1) BG65898B1 (et)
BR (1) BR0017022A (et)
CA (1) CA2394574A1 (et)
CZ (1) CZ299232B6 (et)
DE (1) DE60042836D1 (et)
DK (1) DK1237915T3 (et)
EE (1) EE05293B1 (et)
ES (1) ES2331106T3 (et)
HR (1) HRP20020549B1 (et)
HU (1) HU229001B1 (et)
IL (2) IL150115A0 (et)
LT (1) LT5046B (et)
ME (1) MEP37808A (et)
MX (1) MXPA02005914A (et)
NO (1) NO330924B1 (et)
NZ (1) NZ519598A (et)
PL (1) PL207634B1 (et)
PT (1) PT1237915E (et)
RO (1) RO122543B1 (et)
RS (1) RS50831B (et)
RU (1) RU2283130C2 (et)
SI (2) SI1237915T1 (et)
SK (2) SK286384B6 (et)
WO (1) WO2001044291A2 (et)
ZA (1) ZA200205638B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1251139A3 (en) * 1998-04-08 2002-12-18 Genentech, Inc. Human mindin-like protein and nucleic acids encoding it
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
KR101215218B1 (ko) * 2003-07-22 2012-12-26 바이엘 파마 악티엔게젤샤프트 Ｒｇ１ 항체 및 그의 용도
US7294704B2 (en) * 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2211908A2 (en) * 2007-11-30 2010-08-04 Bristol-Myers Squibb Company Conjugates of anti-rg-1 antibodies
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
DK0814159T3 (da) 1990-08-29 2005-10-24 Genpharm Int Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
AU687001B2 (en) 1992-05-14 1998-02-19 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting cancer development
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6287777B1 (en) 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6177244B1 (en) * 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
AU4236297A (en) * 1996-08-26 1998-03-19 University Of Washington Therapeutic and diagnostic applications of perlecan domain splice variants
AU6961398A (en) 1997-04-10 1998-10-30 Zymogenetics Inc. Secreted f-spondin homologs
JP2002516571A (ja) * 1997-05-06 2002-06-04 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｅｎｔｅｒｏｃｏｃｃｕｓ ｆａｅｃａｌｉｓポリヌクレオチドおよびポリペプチド
JP2001500386A (ja) 1997-05-09 2001-01-16 スミスクライン ビーチャム コーポレーション インテグリンリガンドであるヒトＭｉｎｄｉｎ
NZ507435A (en) 1998-03-10 2003-12-19 Genentech Inc Novel polypeptides and nucleic acids with homology to cornichon
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
WO2000023108A1 (en) 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EE05627B1 (et) * 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
KR100752434B1 (ko) 2007-08-27
IL150115A0 (en) 2002-12-01
RO122543B1 (ro) 2009-08-28
MXPA02005914A (es) 2003-02-27
NZ519598A (en) 2004-03-26
SK286384B6 (sk) 2008-08-05
HRP20020549A2 (en) 2004-04-30
ES2331106T3 (es) 2009-12-22
HRP20020549B1 (hr) 2013-09-30
KR20020065575A (ko) 2002-08-13
IL150115A (en) 2013-11-28
LT2002070A (en) 2003-04-25
NO330924B1 (no) 2011-08-22
US20020004047A1 (en) 2002-01-10
RU2283130C2 (ru) 2006-09-10
YU44602A (sh) 2005-06-10
ZA200205638B (en) 2003-10-15
SI21140A (sl) 2003-08-31
US20040023307A1 (en) 2004-02-05
EP2048157A1 (en) 2009-04-15
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
CA2394574A1 (en) 2001-06-21
EP2048157B1 (en) 2012-10-10
HUP0204224A3 (en) 2004-12-28
HUP0204224A2 (hu) 2003-03-28
JP2003521244A (ja) 2003-07-15
JP4979867B2 (ja) 2012-07-18
DE60042836D1 (de) 2009-10-08
US7893217B2 (en) 2011-02-22
WO2001044291A2 (en) 2001-06-21
SK8482002A3 (en) 2003-02-04
NO20022836D0 (no) 2002-06-14
CZ299232B6 (cs) 2008-05-21
CN1434832A (zh) 2003-08-06
BG106823A (bg) 2003-04-30
PL356220A1 (en) 2004-06-28
RU2002119208A (ru) 2004-02-27
ATE440862T1 (de) 2009-09-15
US20090292112A1 (en) 2009-11-26
AU784674B2 (en) 2006-05-25
BG65898B1 (bg) 2010-04-30
NO20022836L (no) 2002-08-15
US6682902B2 (en) 2004-01-27
EE05293B1 (et) 2010-04-15
SI1237915T1 (sl) 2009-12-31
HU229001B1 (en) 2013-07-29
US20090214422A1 (en) 2009-08-27
BR0017022A (pt) 2002-11-05
WO2001044291A3 (en) 2002-01-17
EP1237915A2 (en) 2002-09-11
LT5046B (lt) 2003-08-25
US7887804B2 (en) 2011-02-15
PL207634B1 (pl) 2011-01-31
CN1297566C (zh) 2007-01-31
SK288147B6 (sk) 2013-12-02
DK1237915T3 (da) 2009-11-16
MEP37808A (en) 2011-05-10
US7307154B2 (en) 2007-12-11
EP1237915B1 (en) 2009-08-26
US20040152139A1 (en) 2004-08-05
AU3074601A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
EE200200323A (et) RG1 polüpeptiidi kodeeriv DNA
ATE406906T1 (de) Von survivin abstammende peptide und deren verwendung
EP1082433A4 (en) Interleukins 21 and 22
ATE365796T1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DK1007686T3 (da) Tuberkulosevaccine
CY1108459T1 (el) Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων
ATE424410T1 (de) Interleukin-19.
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
NO20011460L (no) Cytokinreseptor zalphall
DE60118359D1 (de) Humanische pellino-polypeptide
NZ516237A (en) Meth1 and meth2 polynucleotides and polypeptides
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2001081577A3 (en) Dna encoding the prost 03 polypeptide
ATE554793T1 (de) Konjugat
MY127669A (en) Polypeptide hormone phosphatonin
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
HK1049352A1 (zh) 一种新颖的脱氧核糖核酸编码多肽prost-ets
ATE319739T1 (de) Menschliche wingless-änhliche gene
DE60227367D1 (de) Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
WO2002072770A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20141215